Ani Pharma Private Limited
About Ani Pharma Private Limited
Data last updated:
Ani Pharma Private Limited was a private limited company based in Jalgaon, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 20 January 2015.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U33205MH2015PTC261175. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3.96 Lakh. It was led by directors Aniket Anant Kulkarni and Anant Kalidas Kulkarni.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at Narayan Park, Jalgaon, Maharashtra.
As per the financials filed for FY 2021, the company reported a revenue of ₹10.3 Lakh, a growth of 32% compared to the previous year. For the same year it recorded a net loss of ₹1.84 Lakh (net margin -17.9%) and EBITDA of -₹1.84 Lakh (EBITDA margin -17.9%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 18% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNarayan Park Gat No. 88 Plot No. 14 Block No. 5 Tilak Nagar Behind Gujral Petrol Pump, N. H. 6, Jalgaon, Maharashtra, India – 425001
- IndustryHealthcare, Medical Equipment Retail & Distribution
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ani Pharma Private Limited
The main business activity of Ani Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ani Pharma Private Limited FY 2021 filings available
Ani Pharma Private Limited reported revenue of ₹10.3 Lakh (up 32% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR) of Ani Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 32% growth in the latest year. EBITDA fell 235% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ani Pharma Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.84 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.84 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ani Pharma Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -17.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -17.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ani Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ani Pharma Private Limited
Ani Pharma Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Formulations, Healthcare Equipment Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Particle Therapy Technologies Solution Private Limited | ₹10.31 Lakh (FY 2025) | •••• | •••• | 145.0% | •••• | Chennai, Tamil Nadu, India |
| Phal-Jig Fine Chemicals Private Limited | ₹10.31 Lakh (FY 2025) | •••• | •••• | •••• | Bhavnagar, Gujarat, India | |
| Vitacare Pharma Private Limited | ₹10.31 Lakh (FY 2024) | •••• | •••• | 288.0% | •••• | Delhi, India |
| Curaremedy Medicos (OPC) Private Limited | ₹10.3 Lakh (FY 2024) | •••• | •••• | 0.0% | •••• | Gurugram, Haryana, India |
| Amworld Biotech Private Limited | ₹10.3 Lakh (FY 2021) | •••• | •••• | -91.0% | •••• | Nashik, Maharashtra, India |
| Ani Pharma Private Limited this company | ₹10.3 Lakh (FY 2021) | •••• | •••• | 32.0% | •••• | Jalgaon, Maharashtra, India |
| Cosy Pharmaceuticals Private Limited | ₹10.3 Lakh (FY 2025) | •••• | •••• | -20.0% | •••• | Uttar Pradesh, India |
| Nabhasa Bio-Chem Private Limited | ₹10.3 Lakh (FY 2023) | •••• | •••• | -14.0% | •••• | Bengaluru, Karnataka, India |
| Galaxy Offshore and Oilfield Private Limited | ₹10.22 Lakh (FY 2025) | •••• | •••• | 39.0% | •••• | Mumbai, Maharashtra, India |
| Zarek Pharmaceuticals Private Limited | ₹10.21 Lakh (FY 2024) | •••• | •••• | -9.0% | •••• | New Delhi, Delhi, India |
| Technosurg Sales India Private Limited | ₹10.21 Lakh (FY 2024) | •••• | •••• | 37.0% | •••• | Lucknow, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Ani Pharma by revenue in the Healthcare industry (Formulations, Healthcare Equipment Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Ani Pharma Private Limited
Ani Pharma Private Limited is audited by SATISH S NAIK & CO for the financial year 2016.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SATISH S NAIK & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Ani Pharma Private Limited
Ani Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aniket Anant Kulkarni | Director | 20 Jan 2015 | 11 Years 8 Months | As last reported |
| Anant Kalidas Kulkarni | Director | 20 Jan 2015 | 11 Years 8 Months | As last reported |
Ownership and Shareholding of Ani Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ani Pharma Private Limited
Ani Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ani Pharma Private Limited
Employment history and EPFO contributions of people linked to Ani Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ani Pharma Private Limited
Ani Pharma Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Anant Kalidas Kulkarni was appointed as Director on 20 Jan 2015.
Credit Ratings, Litigation & Regulatory Alerts for Ani Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ani Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ani Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ani Pharma Private Limited
Ani Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ani Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ani Pharma Private Limited
Ani Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Ani Pharma was a private limited company based in Jalgaon, Maharashtra, India. The company worked in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 20 January 2015 and is registered under CIN U33205MH2015PTC261175. The company has been struck off by the Registrar of Companies and is no longer operational.
Ani Pharma had 2 directors:
- Aniket Anant Kulkarni - Director
- Anant Kalidas Kulkarni - Director
The CIN (Corporate Identification Number) of Ani Pharma is U33205MH2015PTC261175. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Ani Pharma is at Narayan Park Gat No. 88 Plot No. 14 Block No. 5 Tilak Nagar Behind Gujral Petrol Pump, N. H. 6, Jalgaon, Maharashtra, India – 425001.
Ani Pharma was incorporated on 20 January 2015. It is registered with the Registrar of Companies, Mumbai.
Ani Pharma reported revenue of ₹10.3 Lakh for FY 2021 (up 32% YoY).
Ani Pharma has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3.96 Lakh.
Ani Pharma reported a net loss of ₹1.84 Lakh (net margin -17.9%) and EBITDA of -₹1.84 Lakh (EBITDA margin -17.9%) for FY 2021, as per its filed financial statements.
No. Ani Pharma has 1 GST registration on record and it is cancelled or inactive.
Ani Pharma operated in the healthcare industry, in the medical equipment retail and distribution segment. It worked in this industry before it was struck off.